Register entry
- Registered sites
- 1
- Active NDC listings
- 1
- Live patents
- 0
- Countries
- 1
- Base
- Germany
Authorisation
Registered operations
Analytical testing1Labelling1Finished drug manufacture1Packaging1
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Haupt Pharma Wuelfing GmbH | Bethelner Landstra�e 18, Gronau (Leine), - 31028, Germany (DEU) | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3003183252333274975 |
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Sulfasalazine | tablet | 57294-021DRUG FOR FURTHER PROCESSING |
Compare
Comparable companies in Germany
- Excella GmbH & Co. KG1 site · 73 NDC
- PEKANA Naturheilmittel GmbH1 site · 62 NDC
- Nestmann Pharma GMBH1 site · 18 NDC
- Rottendorf Pharma GmbH1 site · 17 NDC
- Eckert & Ziegler Radiopharma GmbH1 site · 11 NDC
- Heraeus Precious Metals GmbH Co KG1 site · 10 NDC
- Solupharm Pharmazeutische Erzeugnisse GmbH1 site · 10 NDC
- CU Chemie Uetikon GmbH1 site · 9 NDC
- Thomas Brunner Hygiene GmbH1 site · 8 NDC
- Chemcon GmbH1 site · 7 NDC
Enquiry
Common questions
- Is Haupt Pharma Wuelfing GmbH FDA approved?
- Haupt Pharma Wuelfing GmbH holds 1 FDA-registered establishment in Germany. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Haupt Pharma Wuelfing GmbH's drugs manufactured?
- The FDA register lists Gronau (Leine). Registered operations: analytical testing, labelling, finished drug manufacture, packaging.
- What drugs does Haupt Pharma Wuelfing GmbH make?
- 1 product is listed under Haupt Pharma Wuelfing GmbH in the openFDA NDC Directory, most often as tablet. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.